Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 396
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04473781 | Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer | ||
| NCT00020865 | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia | ||
| NCT01627366 | Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors | ||
| NCT00005629 | Vaccine Therapy in Treating Patients With Liver Cancer | ||
| NCT00070343 | Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301 | ||
| NCT00020878 | Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers | ||
| NCT00039325 | Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma | ||
| NCT01859689 | Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer | ||
| NCT01059513 | Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer | ||
| NCT06090903 | Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma | ||
| NCT05045027 | Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma | ||
| NCT00346372 | Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy | ||
| NCT00004194 | Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease | ||
| NCT00460200 | Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer | ||
| NCT00471887 | Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma | ||
| NCT05523700 | Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) | ||
| NCT03601455 | Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer | ||
| NCT07164027 | Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial | ||
| NCT04282824 | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer | ||
| NCT02940262 | Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy | ||
| NCT01532362 | Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer | ||
| NCT00509431 | Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma | ||
| NCT00344799 | Cytogenetic Study of Ocular Melanoma | ||
| NCT00100997 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate | ||
| NCT00042913 | Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT03425461 | Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma | ||
| NCT00022321 | Gemtuzumab in Treating Patients With Myelodysplastic Syndrome | ||
| NCT00071968 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | ||
| NCT00335868 | PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy | ||
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer | ||
| NCT01005472 | Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma | ||
| NCT07089641 | ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial | ||
| NCT00096057 | Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer | ||
| NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | ||
| NCT02851381 | Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer | ||
| NCT00107159 | Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma | ||
| NCT05160597 | Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy | ||
| NCT00015860 | STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia | ||
| NCT00601289 | Temozolomide in Treating Patients With Invasive Pituitary Tumors | ||
| NCT01070186 | Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma | ||
| NCT03902951 | Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer | ||
| NCT01813877 | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | ||
| NCT02866994 | Project Connect Online: An Internet-based Intervention for Women With Breast Cancer | ||
| NCT00012142 | CCI-779 in Treating Patients With Prostate Cancer | ||
| NCT00255749 | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | ||
| NCT01540955 | Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors | ||
| NCT05115760 | Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy | ||
| NCT02049593 | PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT05775471 | Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer | ||
| NCT00005996 | SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors |
